229 related articles for article (PubMed ID: 23096742)
1. [Role of 18F-FDG-PET/CT in the assessment of carotid atherosclerosis].
Niccoli Asabella A; Di Palo A; Notaristefano A; Ciccone M; Ferrari C; Zeppa P; Cortese F; Rubini G
Recenti Prog Med; 2012 Nov; 103(11):515-9. PubMed ID: 23096742
[TBL] [Abstract][Full Text] [Related]
2. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
[TBL] [Abstract][Full Text] [Related]
3. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
[TBL] [Abstract][Full Text] [Related]
4. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
5. Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
Moon SH; Noh TS; Cho YS; Hong SP; Hyun SH; Choi JY; Kim BT; Lee KH
Angiology; 2015 May; 66(5):472-80. PubMed ID: 24904182
[TBL] [Abstract][Full Text] [Related]
6. Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1.
Wu YW; Kao HL; Chen MF; Lee BC; Tseng WY; Jeng JS; Tzen KY; Yen RF; Huang PJ; Yang WS
J Nucl Med; 2007 Feb; 48(2):227-33. PubMed ID: 17268019
[TBL] [Abstract][Full Text] [Related]
7. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.
Bucerius J; Duivenvoorden R; Mani V; Moncrieff C; Rudd JH; Calcagno C; Machac J; Fuster V; Farkouh ME; Fayad ZA
JACC Cardiovasc Imaging; 2011 Nov; 4(11):1195-205. PubMed ID: 22093271
[TBL] [Abstract][Full Text] [Related]
9. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
[TBL] [Abstract][Full Text] [Related]
10. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
[TBL] [Abstract][Full Text] [Related]
11. Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients.
Skagen K; Johnsrud K; Evensen K; Scott H; Krohg-Sørensen K; Reier-Nilsen F; Revheim ME; Fjeld JG; Skjelland M; Russell D
Int J Stroke; 2015 Jul; 10(5):730-6. PubMed ID: 25588553
[TBL] [Abstract][Full Text] [Related]
12. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
[TBL] [Abstract][Full Text] [Related]
13. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
[TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
Tahara N; Kai H; Nakaura H; Mizoguchi M; Ishibashi M; Kaida H; Baba K; Hayabuchi N; Imaizumi T
Eur Heart J; 2007 Sep; 28(18):2243-8. PubMed ID: 17681956
[TBL] [Abstract][Full Text] [Related]
16. Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study.
Toutouzas K; Koutagiar I; Benetos G; Aggeli C; Georgakopoulos A; Athanasiadis E; Pianou N; Trachanellis S; Patelis N; Agrogiannis G; Kafouris P; Filis K; Bessias N; Klonaris C; Spyrou G; Tsiamis E; Siores E; Patsouris E; Cokkinos D; Tousoulis D; Anagnostopoulos CD
Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1236-1244. PubMed ID: 28011672
[TBL] [Abstract][Full Text] [Related]
17. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
[TBL] [Abstract][Full Text] [Related]
18. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
[TBL] [Abstract][Full Text] [Related]
19. High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
Liu J; Kerwin WS; Caldwell JH; Ferguson MS; Hippe DS; Alessio AM; Martinez-Malo V; Pimentel K; Miyaoka RS; Kohler TR; Hatsukami TS; Yuan C
Int J Cardiovasc Imaging; 2016 Jan; 32(1):145-52. PubMed ID: 26280889
[TBL] [Abstract][Full Text] [Related]
20. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.
Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
